Approval granted by Bulgarian Drug Agency

Bulgarian Drug Agency building in Sofia

Bulgarian Drug Agency building in Sofia

GCT is delighted to announce that we received the approval to conduct a Phase III epilepsy trial in Bulgaria for our long-term partner, a US pharmaceutical company.

The task was completed in just 50 working days.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2018 Global Clinical Trials, LLC

All rights reserved.